Eventually, we summarized the incidence of the somatic mutation and copy number variation (CNV) of 24 regulators in AML patients and showed no obvious relationship among them in terms of genetic alteration in other regulators, except KMT2A that exhibited a significant CNV alteration, including fusion and amplification in copy number (Figure 2D). This evidence concerns the gene KMT2A and acute myeloid leukemia.